All posts by medical

Raising Your First Dollars? The Anatomy Of Startup Pitches That Work – Forbes

Fundraising is one of the most important things a founder can do for their company. But the actual process of fundraising is a bit of a black box. My company asked hundreds of founders to participate in a research project to find out what investors are really looking at when they're reading your pitch deck for a seed investment.

Here are the four things you can do to give yourself the best chance of securing funding for your company.

1. Know who youre aiming for.

There are many ways to make up your initial fundraising round. Most founders start with a friends and family round. This usually leads to a seed (or more commonly now, a pre-seed) round. But there are different types of early stage investors. Two of the most common are angels and institutional investors (VCs). Angels are high net worth individuals who invest their own money, and VCs are part of investment firms that invest their funds in multiple startups to make money for their investors.

Courting angel investors is more time-consuming. We found that founders contacted 68 angels over 13.5 weeks and had 45 meetings. All that work led to just under $1 million in funding. Hackernoon estimates the average angel check at $10,000 to $250,000, so depending on how much you're trying to raise, you could be looking at a lot of small checks to make up your round.

However, when raising money from investment firms, the average founders contacted 29 investors over 9.6 weeks and had 27 meetings. All that netted those founders roughly $2 million in funding. So targeting VCs will typically take less time and lead to more money.

That doesnt mean there isnt a place for angels in your round. Based on the data, you should target a VC firm for your lead investor. But once you have that term sheet in place, you can fill your round out with strategic angels that can offer you key counsel for your company.

2. You dont have to hit them over the head with information.

When youre putting together your pitch deck, youre probably going to try to add way too much information. You know your company best, and its easy to fall into the trap of adding every detail you can think of in order to sway an investor. But the data shows us that you only have a few minutes to make an impression. We found the average time an investor spends reading a pitch deck is only 3 minutes and 44 seconds.

The data shows us that when a deck makes sense, an investor will read through it at a consistent speed. But if they dont understand your deck, or you pack too much information into a single slide, they tend to stop to interpret what theyre looking at. For successful pitch decks (those that resulted in raising money), investors spent around two minutes from start to finish.

This also makes sense considering the average length of a successful pitch deck. Our data tells us you should aim for 19 pages, though Guy Kawasaki recommends keeping it to just 10 slides. Most experts agree your pitch deck should include a few pages on your problem, solution and company purpose, as well as a page on your team and a few pages on your product. You should also include a few slides on the secret sauce for your business.

3. Be clear about your special sauce.

The odds that your company is solving a problem no one has ever thought of is low (but it does happen). Its far more likely that previous companies have tried to solve the problem, but havent quite cracked it. So what separates you from the founders that have come before? One standout in decks that successfully raised was the prevalence of why now or why me slides. Only 46% of decks in our study included a why now section. But 65% of those decks were able to raise money, likely because timing is the biggest predictor of a startups ability to succeed. Investors are looking for the special sauce you bring to the table. A why now slide is a clear way to differentiate yourself.

Some founders will try to show why its the right time to invest by focusing on their financial or traction slides. This can be a blessing or a curse. The data shows that if you include these slides, that's where an investor will focus their time. In fact, theyre going to spend more than double the time on your financial slides than they do on any other section. If you only have an investors time for three minutes, they could spend as much as 25% of that time on your financials.

If youre an early stage startup, your financial slides are likely to show that youve been losing money (which is normal). So unless theres an interesting angle youre trying to show, you can leave these slides out.

4. Give yourself the best chance with timing.

Did you know that the time of year you fundraise can dramatically affect your outcome? We found that there are two clear times when VCs are reading pitch decks. Founders tend to send out most of their pitch decks between August and November. But we found VCs were very active in October and November, but also again from January to March. What this means is that many investors are coming back from the holidays ready to make a deal, but most founders dont start sending their decks out until later in the year. If you want to maximize the chance that a VC is going to read your deck, send it in the first three months of the year.

Good luck, and happy fundraising.

Excerpt from:
Raising Your First Dollars? The Anatomy Of Startup Pitches That Work - Forbes

Is Greys Anatomy On Tonight? ABCs Thanksgiving Schedule Revealed – International Business Times

Thanksgiving can go either way with new TV shows. Some shows will air in their usual time slots while others decide to take a holiday break. This year, Greys Anatomy opted for the latter.

Last week was the fall finale for Greys Anatomy Season 16, and it wont be back until 2020. Instead, ABC will air some family-friendly content on Thanksgiving.

The Wonderful World of Disney: Magical Holiday Celebration airs on Thursday at 8 p.m. EST and will show off a spectacular holiday-themed celebration from Disney World and Disneyland.

Glee alum (and Greys Anatomy guest star) Matthew Morrison hosts alongside Spice Girl Emma Bunton and TV host Jesse Palmer. Viewers will get several Disney Parks sneak peeks, including a behind-the-scenes look into the new Star Wars: Rise of the Resistance attraction. There will also be plenty of musical guests.

The Wonderful World of Disney: Magical Holiday Celebration will be two hours long to fit in all the talent performing at Cinderella Castle at Walt Disney World Resort in Florida and Sleeping Beauty Castle at Disneyland Resort in California.

"Grey's Anatomy" will not air a new episode on Thanksgiving. The show is on hiatus until 2020. Photo: ABC/Mike Rosenthal

Sting and Shaggy will team up to sing a new rendition of Silent Night (Christmas is Coming) while Andy Grammy and Ingrid Michaelson will share an original holiday duet.

Portugal. The Man will give audiences Happy Christmas and Merry Christmas Everybody. Pentatonix will adapt the classics Deck the Halls and Here Comes Santa Claus. Fresh off Dancing With the Stars, Ally Brooke will sing Santa Claus is Coming to Town, and violinist Lindsey Stirling will play Carol of the Bells.

Of course, the talented hosts wont be sidelined. Morrison will entertain audiences with When You Wish Upon A Star from his upcoming album Disney Dreamin with Matthew Morrison and Let it Snow. Bunton, better known as Baby Spice, will sing Santa Baby.

When the two-hour event ends at 10 p.m., ABC will keep it family-friendly with a couple of sitcom reruns. The Goldbergs Season 7, episode 8, titled Angst-Giving, will air first, followed by Modern Family Season 11, episode 3, titled Perfect Pairs.

Greys Anatomy will return to ABC with new episodes on Jan. 23.

See the rest here:
Is Greys Anatomy On Tonight? ABCs Thanksgiving Schedule Revealed - International Business Times

How Love Begins in Queen & Slim – The New York Times

In Anatomy of a Scene, we ask directors to reveal the secrets that go into making key scenes in their movies. See new episodes in the series each Friday. You can also watch our collection of more than 150 videos on YouTube and subscribe to our YouTube channel.

A couple on the lam takes a moment to breathe in this scene from Queen & Slim, directed by Melina Matsoukas.

The sequence finds Queen (Jodie Turner-Smith) and Slim (Daniel Kaluuya) in a juke joint during their flee south after a deadly incident in Cleveland with a police officer. The scene is lit warmly and the mood is in a lower key. And as the two slow dance, feeling protected in this space, they begin to fall in love.

Narrating the scene, Matsoukas discusses her influences for the production design, which include the work of Birney Imes, who photographed juke joints in the Deep South.

Matsoukas took inspiration from other films she loves as well, including West Side Story and Wong Kar-wais In the Mood for Love.

Read the Queen & Slim review.

Sign up for the Movies Update newsletter and get a roundup of reviews, news, Critics Picks and more.

Original post:
How Love Begins in Queen & Slim - The New York Times

Fluicell is Preparing to be the Next Big Player in Swedens Bioprinting Field – 3DPrint.com

Creating innovative tools and high-tech systems for life science researchers around the globe has turned up some fascinating new companies in the last few years; and with Europe currently housing over 35% of biotechnology companies worldwide, we can expect some enticing new discoveries to come. Sweden is certainly not lagging behind, with a buoyant environment for university researchers and students, as well as being known as one of the so-called ideal places to hatch startups, one company is quickly breaking new ground. Founded in 2012 as a spin-off from Chalmers University of Technology, Fluicell is a publicly-traded biotech company providing platforms to investigate cell behavior like never before. Using open-volume microfluidics, they wanr to revolutionize how cells are bioprinted.

Fluicell CEO Victoire Viannay

As a further development to their existing product portfolio, the company has developed a unique high-resolution bioprinting technology in both 2D and 3D called Biopixlar, capable of creating complex tissue-like structures where positioning of individual cells can be controlled from a gamepad, just like you would a videogame. Their original approach is part of a more market-oriented strategy, which brings revolutionary technology straight to the fingertips of users. To get a better sense of what the company is trying to accomplish, 3DPrint.com spoke to Victoire Viannay, Fluicells CEO since 2017.

Since microfluidics is so complex we are trying to create very easy to use platforms for our clients in the life sciences. Our original idea with the Biopixlar was: how to make the system easy to use and fun? So now you can see that we have even incorporated the gamepad, which is a way of creating an easy to use interface, said Viannay.

Biopixlar uses microfluidics which allows for better control of the material at a micro level due to the precision of a pump or microfluidic tube when it comes to directing the flow of biomaterial to actual printing execution. Having such a precise control at the microlevel, systems naturally scale up to the macrolevel and result in high-resolution prints. Additionally, the technology allows the creation of multi-material prints for bioprinting purposes, with users being able to create the materials within the printer technology itself, avoiding the need for laboratory fabrication of the material. A microfluidic chamber can control the mixing of various materials in house. Resulting in a 3D printed structure that is immediately complete without having to deal with gels or scaffolds.

We want to be as true as possible to the science, so it is important for us to protect the landscape, and for that we have a good internal team for harnessing and developing knowledge, knowing that we need to have both invention and method patents.

Fluicell currently has three products on the market, and are now looking actively for partners for the Biopixlar in both Europe and the United States. The research tools Biopen and Dynaflow, allow researchers to investigate the effects of drugs on individual cells at a unique level of detail, as part of their mission to redefine the approach to cell biology, and drug discovery by providing miniaturized instrumentation for single-cell investigations. The company holds a strong IP and patent position with four approved patents in the estate.

Since 2012, the company has moved from Chalmers and established their own laboratories just a few minutes away from the campus, in Gothenburg. There they have commercialized a product portfolio to study single cells, (primarily in the field of drug development), gone public, and launched Biopixlar. Funded by Almi Invest, a local early-stage investor, their aim now is to keep providing innovative tools redefining approaches within cell biology, bioprinting, and secondary drug screening and discovery.

When the company was created we started at Chalmers, but at some point we thought we had to become more independent from the university, so we came up with our own facilities and discovery team, people who work on tissue and disease models in house so that we can do primary research ourselves and the discovery aspects as a way of helping potential clients discover applications which could benefit their needs. We have this both as a demonstration, and also as a contract research organization (CRO) service.

With 20 employees, the company is looking to become the next Swedish bioprinting success, after another company born out of the same city as Fluicell, began selling their popular bioprinters and bioinks, thats Erik Gatenholms CELLINK, now a global big player in biotech. Actually, Viannay claims that Sweden is a great country to start a company, just behind the captivating and successful landscape in the United States.

Sweden is very supportive of new companies. The whole country is built upon innovation, proving that its people were never afraid to try out new things, so it should be the same with bioprinting. Right now there is a very good landscape to work on our projects and i really think that Sweden is ready to support more bioprinting initiatives, suggested Viannay, who is originally French and moved to Sweden after meeting her husband. She has proved to be a great match for the company because of her strong background in law. With a PhD in the field from the Universit Paris II Panthon/Assas and over more than 10 years of experience in labor laws, human resources and legal management, particularly in the field of scientific research, her incorporation came in at just the right time. Her knowledge came in handy during the companys IPO in early 2018.

Two lab experts at Fluicell using the gamepad to control the Biopixlar system

Fluicell has a good growth model based on market penetration, acquiring new geographic areas and expansion and market diversification. So it has worked very well for us while growing the company, next we would be interested in being a profitable company that is very well recognized in the world thanks to our products, which began with the Biopen, and had great traction among our customers. For our Biopixlar technology we would like to further target other areas, such as regenerative medicine, moving towards building tissues and taking it outside of pure research and development by using it to develop something that can go into regenerative or therapeutic medicine.

Join the discussion of this and other 3D printing topics at3DPrintBoard.com.

Read more:
Fluicell is Preparing to be the Next Big Player in Swedens Bioprinting Field - 3DPrint.com

Tendon stem cell discovery could lead to improvements in injury recovery – Drug Target Review

Researchers have discovered the existence of tendon stem cells, which could lead to improvements in treating tendon injuries, avoiding surgery.

New research has revealed the existence of tendon stem cells which could potentially be harnessed to improve tendon recovery after an injury and perhaps even avoid surgery.

The research was led by Chen-Ming Fan at the Carnegie Institution of Science, US.

Once tendons are injured, they rarely fully recover, which can result in limited mobility and require long-term pain management or even surgery. This is due to fibrous scars, which disrupt the tissue structure of the tendon.

This image shows the Patellar tendon 30 days after an injury. The red marks newly discovered tendon stem cells that have self-renewed and are layered over green marked, original tendon cells. During regeneration, some tendon stem cells differentiate to make newly regenerated tendon cells a process during which they transition into a yellow-orange colour. The blue indicates cellular nuclei (credit: Tyler Harvey).

Fan, along with Carnegies Tyler Harvey and Sara Flamenco, revealed all of the cell types present in the Patellar tendon, found below the kneecap, including previously undefined tendon stem cells.

Because tendon injuries rarely heal completely, it was thought that tendon stem cells might not exist, said lead author Harvey. Many searched for them to no avail, but our work defined them for the first time.

The teams research showed that both fibrous scar tissue cells and tendon stem cells originate in the same space the protective cells that surround a tendon. Moreover, these tendon stem cells are part of a competitive system with precursors of fibrous scars, which explains why tendon healing is such a challenge.

It was thought that tendon stem cells might not exist but our work defined them for the first time

The team demonstrated that both tendon stem cells and scar tissue precursor cells are stimulated into action by a protein called platelet-derived growth factor-A. When tendon stem cells are altered so that they do not respond to this growth factor, then only scar tissue and no new tendon cells form after an injury.

Tendon stem cells exist, but they must outcompete the scar tissue precursors in order to prevent the formation of difficult, fibrous scars, Fan explained. Finding a therapeutic way to block the scar-forming cells and enhance the tendon stem cells could be a game-changer when it comes to treating tendon injuries.

The research was published in Nature Cell Biology.

View original post here:
Tendon stem cell discovery could lead to improvements in injury recovery - Drug Target Review

Organ-on-Chip Market professional study and Future Opportunities: Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems – Market Expert

The organs-on-chips market is expected to reach USD 45.6 million by 2026 from USD 9.6 million in 2017, at a CAGR of +37%.

OOC (organ-on-a-chip) is a multichannel 3D microfluidic cell culture chip that simulates the activity, dynamics and physiological responses of the entire organ and organ system, a type of artificial organ. It constitutes the subject of more precise biomedical engineering research in the biomedical field. Convergence of laboratory-on-chip (LOC) and cell biology has introduced a new model of in vitro multicellular human organisms, allowing the study of human physiology in organ-specific contexts. One day they will abolish the need for animals in drug development and toxin testing.

Request for sample copy:https://healthcareintelligencemarkets.com/request_sample.php?id=116026

The examination report, titled Organ-on-Chip offers an unmistakable comprehension of the subject matter. The report provides a clear understanding of the market dynamics. The report uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the upcoming years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions.

Competition Analysis: Some of key competitors or manufacturers included in the study are Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory

Global market, By Type

Liver-on-a-chip

Kidney-on-a-chip

Intestine-on-a-chip

Lung-on-a-chip

Heart-on-a-chip

Other Organs

Global market, By Applications

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Cosmetics Industry

Other End Users

Key Questions Answered in Report:

Get Reasonable Discount on this Premium Report @:https://healthcareintelligencemarkets.com/ask_for_discount.php?id=116026

The report is also equipped with a regional outlook of several global regions such as North America, Europe, Asia-Pacific, Latin America. The Organ-on-Chip Market has been gauged owning to production, manufacturing cost and along with the product specifications. The report thus sheds light on the threats and challenges of the business. . The report has been aggregated on the basis of recent scope, challenges in front of the businesses, and global opportunities to enlarge the sector during the forecast period.

Major Points from Table of Content:

For More Information:https://healthcareintelligencemarkets.com/enquiry_before_buying.php?id=116026

About Us:

At HealthCare Intelligence Markets

Contact Us:

Address: 90, State Office Center,

90, State Street Suite 700,

Albany, NY 12207

Email: sales@healthcareintelligencemarkets.com

Web: http://www.healthcareintelligencemarkets.com

Phone: +1 (888) 616-2766

Read the original post:
Organ-on-Chip Market professional study and Future Opportunities: Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems - Market Expert

The Sound of Science – ‘Non-Newtonian Fluids Pt. 2’ – WNIJ and WNIU

The Sound of Science - 'Non-Newtonian Fluids Pt. 2' (November 29, 2019)

Sam: Welcome to the Sound of Science on WNIJ. Im Sam from NIU STEM Outreach.

Nicole: and Im Nicole James from NIU Department of Chemistry and Biochemistry. I researched non-Newtonian fluids like Oobleck for my PhD.

Sam: Oobleck is a cornstarch and water mixture that acts kinda funny. Its runny and goopy until you apply a sudden force, then it feels solid. Its one of many non-Newtonian fluids.

Nicole: Non-Newtonian fluids are fluids that change their viscosity based on how theyre treated. Theyre called this because they dont follow conventional Newtonian fluid dynamics. While Oobleck is one of the most famousand one of the most extreme, its certainly not the only one in our lives. There are lots of things that thicken or thin as you stir them.

Sam: These fluids are more common than you might think. Take a look in your fridge and youll probably see two: Ketchup and mayonnaise. Its hard to get them out of their bottles, but they spread very easily. They thin out when force is applied.

Nicole: A lot of every-day fluids are engineered to be non-Newtonian. Imagine trying to paint a wall with really thin paint. It would drip and smear and make an awful mess. Also imagine trying to mix up a really thick paint. It wouldnt mix full or it would take forever. Latex paints are designed to be really thick at rest, say when the paint is already on the wall, so it doesnt drip.However, when youre stirring it or brushing it on, its thin so that its easy to stir and flows smoothly on the wall.

Sam: While a slew of examples is neat, you might be wondering why knowing about non-Newtonian fluids are important at all. With synthesized and engineered non-Newtonian fluids, we can find practical applications in healthcare and security.

Nicole: Imagine clothing or gloves that are puncture-resistant because there is a thin layer of non-Newtonian material that turns stiff or solid with an increased force. Prison guards could be that much safer from stab wounds. Doctors and nurses wearing special gloves would be protected from infections and accidental needle-sticks.

Sam: Foods, home dcor, and healthcare! Non-Newtonian fluids go beyond goop for kids! We hope we got your thoughts flowing here on The Sound of Science on WNIJ.

Nicole: Where you learn something new every day.

Read the original:
The Sound of Science - 'Non-Newtonian Fluids Pt. 2' - WNIJ and WNIU

Cunningham’s Textbook of Veterinary Physiology, 6th Edition – ResearchAndMarkets.com – Yahoo Finance

DUBLIN--(BUSINESS WIRE)--

The "Cunningham's Textbook of Veterinary Physiology. Edition No. 6" book has been added to ResearchAndMarkets.com's offering.

Learn how to understand normal body functions before learning about the mechanisms of veterinary disease. Cunningham's Textbook of Veterinary Physiology, 6th Edition approaches this vast subject in a practical, user-friendly way that helps you grasp key concepts and learn how they relate to clinical practice. From cell physiology to body system function to homeostasis and immune function, this comprehensive text provides the solid foundation needed before advancing in the veterinary curriculum.

Key Topics Covered:

Section I: The Cell

1. The Molecular and Cellular Bases of Physiological Regulation

2. Cancer: A Disease of Cellular Proliferation, Life Span, and Death

Section II: Neurophysiology

3. Introduction to the Nervous System

4. The Neuron

5. The Synapse

6. The Physiology of Muscle

7. The Concept of a Reflex

8. Skeletal Muscle Receptor Organs

9. The Concept of Lower and Upper Motor Neurons and Their Malfunction

10. The Central Control of Movement

11. The Vestibular System

12. The Cerebellum

13. The Autonomic Nervous System

14. The Visual System

15. Cerebrospinal Fluid and the Blood-Brain Barrier

16. The Electroencephalogram and Sensory-Evoked Potentials

17. Hearing

Section III: Cardiovascular Physiology

18. Overview of Cardiovascular Function

19. Electrical Activity of the Heart

20. The Electrocardiogram

21. The Heart as a Pump

22. The Systemic and Pulmonary Circulations

23. Capillaries and Fluid Exchange

24. Local Control of Blood Flow

25. Neural and Hormonal Control of Blood Pressure and Blood Volume

26. Integrated Cardiovascular Responses

Section IV: Physiology of the Gastrointestinal Tract

27. Regulation of the Gastrointestinal Functions

28. Motility Patterns of the Gastrointestinal Tract

29. Secretions of the Gastrointestinal Tract

30. Digestion and Absorption: The Nonfermentative Processes

31. Digestion: The Fermentative Processes

32. Postabsorptive Nutrient Utilization

Section V: Endocrinology

33. The Endocrine System

34. Endocrine Glands and Their Function

Section VI: Reproduction and Lactation

35. Control of Gonadal and Gamete Development

36. Control of Ovulation and the Corpus Luteum

37. Reproductive Cycles

38. Pregnancy and Parturition

39. The Mammary Gland

40. Reproductive Physiology of the Male

Section VII: Renal Physiology

41. Glomerular Filtration

42. Solute Reabsorption

43. Water Balance

44. Acid-Base Balance

Section VIII: Respiratory Function

45. Overview of Respiratory Function: Ventilation of the Lung

46. Pulmonary Blood Flow

47. Gas Exchange

48. Gas Transport in the Blood

49. Control of Ventilation

50. Nonrespiratory Functions of the Lung

Section IX: Homeostasis

51. Fetal and Neonatal Oxygen Transport

52. Acid-Base Homeostasis

53. Thermoregulation

Section X: The Immune System

54. Antigens and Innate Immunity

55. The Specific Immune Response: Acquired Immunity

Author

For more information about this book visit https://www.researchandmarkets.com/r/qi97ld

View source version on businesswire.com: https://www.businesswire.com/news/home/20191129005135/en/

Read the original here:
Cunningham's Textbook of Veterinary Physiology, 6th Edition - ResearchAndMarkets.com - Yahoo Finance

Got An Idea To Save Bats From White-Nose Syndrome? The Government Wants To Hear It! – KUT

White-nose syndrome, a fungal disease that has decimated bat populations, is spreading in Texas. Scientists are trying everything from vaccines to UV lights to control the disease. Now, theyre asking the public for help.

The U.S. Fish and Wildlife Service has started accepting ideas to fight white-nose syndrome.If your idea is picked as one of the most promising, you could win up to $20,000 and work with scientists to test it out.

The website for the contestsays it is open to any idea to permanently eradicate, weaken, or disarm the fungus that causes white-nose syndrome.

Were trying to sort of not restrict the thinking on any of this, says Jonathan Reichard, assistant coordinator for the service's national white-nose syndrome response. We really want very open minds on what ideas can come in.

Earlier this year, the Texas Parks and Wildlife Department announced the fungus causing the disease had been found in 11 newcounties in the state, including the Bracken Bat Cave in San Antonio, the worlds largestbat colony.

That cave, like under the Ann Richards Bridge in Austin, is home to millions of Mexican free-tailed bats.

The good news is that Mexican free-tailed bats migrate during the winter rather than hibernate. And white-nose syndrome kills bats during hibernation, Jonah Evans, a mammalogist with Texas Parks and Wildlife, told KUT at the time.

While the bats are away, Texas Parks and Wildlife is disinfecting manmade bat roostslike bridges in East Texas to see if it might slow or stop the spread of the fungus.

Reichard said researchers are also trying to figure out how some bats have managed to survive the plague of white-nose syndrome in the Northeast, where its impact has been nearly apocalyptic.

Theres ongoing work to figure out what it is thats helping those bats survive, he says. It could be anything from their physiology to the environment they chose to live in the winter time.

The U.S. Fish and Wildlife Service will accept ideas for its white-nose syndrome contest until the end of the year.

Read the original here:
Got An Idea To Save Bats From White-Nose Syndrome? The Government Wants To Hear It! - KUT